Searchable abstracts of presentations at key conferences in endocrinology

ea0025p231 | Pituitary | SFEBES2011

Tri-phasic changes in sodium levels post pituitary surgery

Ellis Hollie , Webb David , Robertson Iain , Howlett Trevor , Levy Miles

Case: A 73-year-old lady presented with hyponatraemia six days post-transphenoidal surgery for a non functioning pituitary macro-adenoma. Peri-operatively she developed diabetes insipidus requiring short term desmopressin whilst on the neurosurgical ward. At post-operative presentation she complained of weakness, confusion and nausea; sodium 125 mmol/l, serum osmolality 268 mOsmol/kg, urine osmolality 474 mOsmol/kg. Over the next few days she became symptomatically worse and h...

ea0015p42 | Clinical practice/governance and case reports | SFEBES2008

Audit of local management of primary hyperparathyroidism: would local guidelines aid management?

McGeoch Susan , Robertson Douglas , Bal Satinder , MacRury Sandra

Primary hyperparathyroidism is a common endocrine disorder. Diagnosis is more frequently made where calcium testing forms part of routine screening bloods. The clinical profile has shifted from a symptomatic disorder with hypercalcaemic symptoms, kidney stones and overt bone disease towards a more asymptomatic state. The National Institutes of Health (NIH) have produced guidelines on diagnosis and management of primary hyperparathyroidism but no UK guidelines are in existence....

ea0011p268 | Diabetes, metabolism and cardiovascular | ECE2006

Increased expression of the adipokines resistin and fiaf in hypoxic/ischemic mouse brain

Wiesner G , Brown RE , Robertson GS , Ur E , Wilkinson M

Obesity and adipokines are associated with a state of chronic low grade inflammation (Trayhurn & Wood 2004).In view of our findings that the adipokines resistin and fiaf (fasting-induced adipose factor) are also expressed in mouse brain and pituitary gland (Wiesner et al 2004), we tested the hypothesis that these factors would be induced in brain tissue following cerebral hypoxia/ischemia (H/I). Neonatal H/I (postnatal day 8; unilateral common c...

ea0011p517 | Endocrine tumours and neoplasia | ECE2006

A retrospective review of the effect of pituitary radiotherapy after transsphenoidal surgery for non-functioning pituitary adenomas

Chellamuthu P , Robertson I , Levy MJ , Howlett TA

Background: The role of post-operative radiotherapy (RT) in the treatment of non-functioning pituitary adenomas (NFA) remains controversial. We compared the difference in outcome between patients receiving transsphenoidal surgery (TSS) alone and TSS plus RT in 93 patients treated for NFA between 1986 and 2005. 64 (69%) had TSS alone whilst 29 (31%) received TSS plus RT (45GY, 25Fr, 3 field). All patients were followed up by CT and then MRI scans repeated at increasing interval...

ea0009p180 | Clinical | BES2005

Pituitary Apoplexy. Retrospective review of 28 patients: is surgical intervention always necessary?

Gruber A , Kumar S , Robertson I , Howlett T , Mansell P

We report 28 patients (21M 7F; 17-86y) with pituitary apoplexy presenting between 1988 and 2004. Presenting features included: headache in 25 patients, 'collapse' in 3, vomiting in 13, complete blindness in 4, decreased visual acuity in 13, visual field loss in 12 and ophthalmoplegia in 16. Only 4 had no initial visual deficit. Predisposing factors included a known pituitary tumour in 4 patients, anticoagulant therapy in 3 patients and ITP in 1 patient. CT was initial imaging ...

ea0009p185 | Clinical | BES2005

Appropriate management of CAH requires detailed mutational analysis to be interpreted within the context of family history and biochemistry

Davis N , Robertson S , Burren C , Crowne E

We present two families illustrating complex management issues introduced by mutational analysis in CAH.Family 1. A female index case presented at birth with ambiguous genitalia and was diagnosed with severe salt losing CAH. She is a compound heterozygote with two severe mutations: 659G (intron 2 splice site mutation) from her mother and CYP21 deletion from her father. Mother and mother's identical twin sister have compound heterozygosity for the mild mu...

ea0077p215 | Neuroendocrinology and Pituitary | SFEBES2021

Prevalence of cholelithiasis in somatostatin analogues treated Acromegaly patients

Sim Sing , Mavilakandy Akash , Bremner Emma , Barrowcliffe Mary , Bhake Ragini , Robertson Iain , Levy Miles , Reddy Narendra

Background: World Gastroenterology Organisation (WGO) quotes gallstones prevalence of 9-21%, incidence of 0.63/100 persons/year in Europe; 10-15% of UK population have gallstones (1). Acromegaly patientsÂ’ prevalence is 8.3% and 35% developing incidental gallstones during somatostatin analogue (SSA) treatment (2).Objective: To evaluate the prevalence of gallstones in SSA treated Acromegaly patients in University Hospitals of Leicester (UHL).<p cl...

ea0044p32 | Adrenal and Steroids | SFEBES2016

Discovery of putative aldosterone-regulating microRNAs by analysis of in vitro and in vivo microRNA profiles

Ab Razak Nur Izah , MacKenzie Scott , Robertson Stacy , McBride Martin , Freel Marie , Davies Eleanor

Approximately 10% of essential hypertension cases is attributed to primary aldosteronism (PA), where inappropriately high levels of aldosterone are secreted. Almost half of these PA cases result from aldosterone-producing adenoma. microRNAs are single-stranded, short non-coding RNAs that negatively regulate gene expression post-transcriptionally. In a previous study, we showed that microRNAs directly modulate CYP11B2 (aldosterone synthase) gene expression and aldoster...

ea0034p390 | Thyroid | SFEBES2014

Factors contributing to high levothyroxine doses in primary hypothyroidism; an interventional audit of a large community database

Robertson Hannah , Narayanaswamy Anil , Pereira Olivia , Copland Shirley , Herriot Richard , McKinlay Alastair , Bevan John , Abraham Prakash

Background: While few hypothyroid patients require more than the expected weight related dose of levothyroxine, the underlying causes of larger-than-expected dosing requirements have not been studied in a single cohort. Our aim was to determine and quantify the multiple factors contributing to high dose levothyroxine requirements in a cohort of patients with hypothyroidism.Methods: The Grampian Automated Follow-Up Register (GAFUR) monitors around 17 500 ...

ea0077p217 | Neuroendocrinology and Pituitary | SFEBES2021

Comparison of cardiovascular outcomes of radiotherapy vs non-radiotherapy cohort of Acromegaly patients

Mavilakandy Akash , Bhake Ragini C , Bremner Emma , Barrowcliffe Mary , Robertson Iain , Levy Miles J , Reddy Narendra L

Background: Radiotherapy is a third line treatment in Acromegaly. Pituitary radiotherapy (RT) is known to have cardiovascular complications (MI/IHD, CCF & CVA) due to radiation effects on normal pituitary and surrounding structures over and above the excess Growth hormone risk on metabolism (1).Objective: To compare RT vs non-RT treated Acromegaly cohortsÂ’ cardiovascular (CV) outcomes in unselected consecutive Acromegaly patients.<p class="a...